---
figid: PMC5067332__IJE2016-5616807.001
figlink: /pmc/articles/PMC5067332/figure/fig1/
number: F1
caption: Inositol mechanisms of action in cancer cells. Inositols (INS), including
  InsP6 and myo-Ins, modulate a number of different critical pathways. Available data
  suggest that the inhibition of the phosphorylation-based (P) activation of key molecular
  targets represents a basic mechanism through which inositol interferes with specific
  biological functions, eventually ending up in delaying cell replication and in fostering
  apoptosis or phenotypic differentiation. (A) Inositols inhibit pRB phosphorylation,
  thus fostering the pRB/E2F complexes formation and blocking further progression
  along the cell cycle. (B) Phosphatidylinositol-4,5-bisphosphonate (PIP2) is metabolized
  to diacylglycerol (DAG) and Ins-trisphosphate (IP3) by phospholipase-C (PLC). Moreover,
  PI3K catalyzes the synthesis of PIP3 from PIP2. PIP3 is required for enabling the
  activation of ERK and Akt pathways. Indeed, by reducing both PI3K levels and its
  activity, inositols counteract the activation of the PKC/RAS/ERK pathway. Upstream
  of that pathway, inositols disrupt the ligand interaction between FGF and its receptor
  (FGF-r) by interfering with syndecan (Synd) activity as well as with the EGF-transduction
  processes involving IGF-II receptor and AP-1 complexes. Downstream of PI3K inhibition,
  Akt activation through selective phosphorylation promoted by PDK and mTORC2 is severely
  impaired upon inositol addition. Downregulation of both Akt and ERK leads consequently
  to NF-kB inhibition and reduced expression of inflammatory markers, like COX-2 and
  PGE2. Inositol-induced downregulation of presenilin-1 (PS1), when associated with
  inhibition of the PI3K/Akt pathway, counteracts the epithelial-mesenchymal transition
  (EMT), thus reducing Wnt-activation, β-catenin (β-cat) translocation, Notch-1, N-cadherin
  (N-cad), and SNAI1 release. Inositols interfere also directly with different cytoskeleton
  components by upregulating Focal Adhesion Kinase (FAK) and E-cadherin (Ec) and decreasing
  Fascin (F) and Cofilin, two main components of the pseudopodia. Reduced formation
  of membrane ruffling and pseudopodia, as well as inhibited release of metalloproteinases
  (MMPs), severely impairs both motility and invasiveness of cancer cells. This effect
  is reinforced by the inositol-induced inhibition on ROCK1/2 release, as well as
  by the decreased levels of phosphorylated Myosin Light Chain (MLC). Overall, these
  effects enable inositols to remodel F-actin (A) assembly and thus to reshape the
  cytoskeleton architecture. Blue arrow indicates promoting effect; red line with
  bar indicates inhibitory effect.
pmcid: PMC5067332
papertitle: Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate.
reftext: Mariano Bizzarri, et al. Int J Endocrinol. 2016;2016:5616807.
pmc_ranked_result_index: '102408'
pathway_score: 0.9787617
filename: IJE2016-5616807.001.jpg
figtitle: Inositol mechanisms of action in cancer cells
year: '2016'
organisms:
- Mus musculus
- Rattus norvegicus
- Glycine max
- Oryza sativa
- Triticum aestivum
- Saccharomyces cerevisiae
- Cyprinus carpio
- Homo sapiens
- Sus scrofa
- Oryctolagus cuniculus
ndex: 898e7074-debd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5067332__IJE2016-5616807.001.html
  '@type': Dataset
  description: Inositol mechanisms of action in cancer cells. Inositols (INS), including
    InsP6 and myo-Ins, modulate a number of different critical pathways. Available
    data suggest that the inhibition of the phosphorylation-based (P) activation of
    key molecular targets represents a basic mechanism through which inositol interferes
    with specific biological functions, eventually ending up in delaying cell replication
    and in fostering apoptosis or phenotypic differentiation. (A) Inositols inhibit
    pRB phosphorylation, thus fostering the pRB/E2F complexes formation and blocking
    further progression along the cell cycle. (B) Phosphatidylinositol-4,5-bisphosphonate
    (PIP2) is metabolized to diacylglycerol (DAG) and Ins-trisphosphate (IP3) by phospholipase-C
    (PLC). Moreover, PI3K catalyzes the synthesis of PIP3 from PIP2. PIP3 is required
    for enabling the activation of ERK and Akt pathways. Indeed, by reducing both
    PI3K levels and its activity, inositols counteract the activation of the PKC/RAS/ERK
    pathway. Upstream of that pathway, inositols disrupt the ligand interaction between
    FGF and its receptor (FGF-r) by interfering with syndecan (Synd) activity as well
    as with the EGF-transduction processes involving IGF-II receptor and AP-1 complexes.
    Downstream of PI3K inhibition, Akt activation through selective phosphorylation
    promoted by PDK and mTORC2 is severely impaired upon inositol addition. Downregulation
    of both Akt and ERK leads consequently to NF-kB inhibition and reduced expression
    of inflammatory markers, like COX-2 and PGE2. Inositol-induced downregulation
    of presenilin-1 (PS1), when associated with inhibition of the PI3K/Akt pathway,
    counteracts the epithelial-mesenchymal transition (EMT), thus reducing Wnt-activation,
    β-catenin (β-cat) translocation, Notch-1, N-cadherin (N-cad), and SNAI1 release.
    Inositols interfere also directly with different cytoskeleton components by upregulating
    Focal Adhesion Kinase (FAK) and E-cadherin (Ec) and decreasing Fascin (F) and
    Cofilin, two main components of the pseudopodia. Reduced formation of membrane
    ruffling and pseudopodia, as well as inhibited release of metalloproteinases (MMPs),
    severely impairs both motility and invasiveness of cancer cells. This effect is
    reinforced by the inositol-induced inhibition on ROCK1/2 release, as well as by
    the decreased levels of phosphorylated Myosin Light Chain (MLC). Overall, these
    effects enable inositols to remodel F-actin (A) assembly and thus to reshape the
    cytoskeleton architecture. Blue arrow indicates promoting effect; red line with
    bar indicates inhibitory effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF17
  - RICTOR
  - FGF16
  - FGF19
  - FGFR4
  - FGFR3
  - FGFR2
  - MLST8
  - FGFR1
  - MTOR
  - PRKCD
  - NFKB2
  - MAPKAP1
  - CDH2
  - NFKB1
  - MAP2K1
  - FGFRL1
  - IGF2
  - PRKCB
  - FGF18
  - AKT3
  - AKT1
  - AKT2
  - FOS
  - FOSB
  - FOSL2
  - PLCZ1
  - INS
  - PDK1
  - PRKD3
  - PRKCA
  - FGF23
  - NRAS
  - ROCK1
  - ROCK2
  - SNAI1
  - WNT2B
  - WNT16
  - WNT4
  - REL
  - ARAF
  - RAF1
  - BRAF
  - MAP2K2
  - MLC1
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - RELA
  - RELB
  - PTK2
  - FGF1
  - FGF2
  - PLCE1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCG1
  - PLCG2
  - PLCD4
  - E2F8
  - JUN
  - JUNB
  - JUND
  - HRAS
  - KRAS
  - E2F7
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - FGF10
  - EGF
  - MAPK3
  - MAPK1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - FGF7
  - FGF8
  - FGF9
  - WNT9A
  - FGF11
  - FGF12
  - FGF20
  - FGF21
  - FGF22
  - FOSL1
  - CFL1
  - CFL2
  - DSTN
  - WNT9B
  - WNT10B
  - WNT11
  - WNT3
  - FGF14
  - WNT1
  - WNT2
  - PRKCQ
  - FGF13
  - PLCB1
  - WNT3A
  - PRKCZ
  - WNT10A
  - WNT5B
  - PLCD3
  - PGE2
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF-r
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGF-r
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGF-r
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: FGF-r
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: N-cad
  symbol: NCAD
  source: hgnc_prev_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGF-r
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: IGF-II
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: INS
  symbol: INS
  source: hgnc_symbol
  hgnc_symbol: INS
  entrez: '3630'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ROCK1
  symbol: ROCK1
  source: hgnc_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: ROCK2
  symbol: ROCK2
  source: hgnc_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: SNAIL
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MLC
  symbol: MLC
  source: hgnc_alias_symbol
  hgnc_symbol: MLC1
  entrez: '23209'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: (E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: Cofilin
  symbol: Cofilin
  source: bioentities_symbol
  hgnc_symbol: CFL1
  entrez: '1072'
- word: Cofilin
  symbol: Cofilin
  source: bioentities_symbol
  hgnc_symbol: CFL2
  entrez: '1073'
- word: Cofilin
  symbol: Cofilin
  source: bioentities_symbol
  hgnc_symbol: DSTN
  entrez: '11034'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5067332__F1
redirect_from: /figures/PMC5067332__F1
figtype: Figure
---
